Ptc Therapeutics (PTCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -29,271 | -14,684 | -26,230 | -19,963 | -12,666 |
| Depreciation Amortization | 1,222 | 625 | 2,700 | 2,049 | 1,381 |
| Accounts receivable | 143 | 68 | 230 | 76 | -74 |
| Other Working Capital | -7,745 | -378 | -25,120 | -19,178 | -19,048 |
| Other Operating Activity | 8,369 | 6,522 | 500 | 126 | -289 |
| Operating Cash Flow | $-27,282 | $-7,847 | $-47,920 | $-36,891 | $-30,695 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -11,584 | N/A | N/A | N/A | N/A |
| PPE Investments | -96 | -21 | -180 | -184 | -179 |
| Investing Cash Flow | $-11,680 | $-21 | $-180 | $-184 | $-179 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -2,174 | -1,069 | -6,944 | -6,240 | -4,741 |
| Common Stock Issued | 131,720 | N/A | N/A | 0 | N/A |
| Other Financing Activity | 60,785 | 56,458 | 29,354 | 29,355 | 29,432 |
| Financing Cash Flow | $190,331 | $55,389 | $22,410 | $23,115 | $24,691 |
| Beginning Cash Position | 2,726 | 2,726 | 28,430 | 28,431 | 28,431 |
| End Cash Position | 154,095 | 50,247 | 2,720 | 14,472 | 22,249 |
| Net Cash Flow | $151,369 | $47,521 | $-25,700 | $-13,960 | $-6,183 |
| Free Cash Flow | |||||
| Operating Cash Flow | -27,282 | -7,847 | -47,920 | -36,891 | -30,695 |
| Capital Expenditure | -96 | -21 | -189 | -184 | -179 |
| Free Cash Flow | -27,378 | -7,868 | -48,109 | -37,074 | -30,874 |